BRENT MONTAGUE HARDIN NPI 1598921892

NPI Details

Brent Montague Hardin is an urology in Oxford, MS with 13 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. Brent Montague Hardin NPI is 1598921892. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE
Graduation Year:2013

The provider's business location address is:

1201 MEDICAL PARK DR
OXFORD, MS
ZIP 38655-327
Phone: (662) 234-1448
Fax: (662) 234-1490

The NPI 1598921892 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, degarelix, 1 mg (HCPCS:J9155)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Automated urinalysis test (HCPCS:81003)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Injection, mitomycin, 5 mg (HCPCS:J9280)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Testosterone (hormone) level, total (HCPCS:84403)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Detection test by nucleic acid for organism, quantification (HCPCS:87799)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Simple change of bladder tube (HCPCS:51705)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, tobramycin sulfate, up to 80 mg (HCPCS:J3260)
• Blood creatinine level (HCPCS:82565)
• Biopsy of bladder using an endoscope (HCPCS:52204)
• Limited ultrasound scan of pelvis (HCPCS:76857)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Biopsy of prostate gland (HCPCS:55700)
• Insertion of temporary bladder tube (HCPCS:51701)
• Ct scan of abdomen without contrast (HCPCS:74150)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Ct scan of abdomen with contrast (HCPCS:74160)
• Creation of sling around urethra in female to control leakage (HCPCS:57288)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Ct scan of abdomen before and after contrast (HCPCS:74170)
• Dilation of bladder using an endoscope under general or spinal anesthesia (HCPCS:52260)
• Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope (HCPCS:52001)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Detection test by nucleic acid for legionella pneumophila (water borne bacteria), quantification (HCPCS:87542)
• Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique (HCPCS:87541)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 8/6/2008 and was last updated on 5/14/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: